Hubbry Logo
Mammary glandMammary glandMain
Open search
Mammary gland
Community hub
Mammary gland
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Mammary gland
Mammary gland
Mammary gland
View on Wikipedia
from Wikipedia

Mammary gland
Cross-section of the human mammary gland:
Details
PrecursorMesoderm
 (blood vessels and connective tissue)
Ectoderm[3]
 (cellular elements)
ArteryInternal thoracic artery
Lateral thoracic artery[1]
VeinInternal thoracic vein
Axillary vein[1]
NerveSupraclavicular nerves
Intercostal nerves[2]
 (lateral and medial branches)
LymphPectoral axillary lymph nodes[1]
Identifiers
TA98A16.0.02.006
TA27099
FMA60088
Anatomical terminology

A mammary gland is an exocrine gland that produces milk in humans and other mammals. Mammals get their name from the Latin word mamma, "breast". The mammary glands are arranged in organs such as the breasts in primates (for example, humans and chimpanzees), the udder in ruminants (for example, cows, goats, sheep, and deer), and the dugs of other animals (for example, dogs and cats) to feed young offspring. Lactorrhea, the occasional production of milk by the glands, can occur in any mammal, but in most mammals, lactation, the production of enough milk for nursing, occurs only in phenotypic females who have gestated in recent months or years. It is directed by hormonal guidance from sex steroids. In a few mammalian species, male lactation can occur. With humans, male lactation can occur only under specific circumstances.

Mammals are divided into 3 groups: monotremes, metatherians, and eutherians. In the case of monotremes, their mammary glands are modified sebaceous glands and without nipples. Concerning most metatherians and eutherians, only females have functional mammary glands, with the exception of some bat species. Their mammary glands can be termed as breasts or udders. In the case of breasts, each mammary gland has its own nipple (e.g., human mammary glands). In the case of udders, pairs of mammary glands comprise a single mass, with more than one nipple (or teat) hanging from it. For instance, cows and buffalo udders have two pairs of mammary glands and four teats, whereas sheep and goat udders have one pair of mammary glands with two teats protruding from the udder. Each mammary gland produces milk for a single teat and is evolutionarily derived from modified sweat glands.

Structure

[edit]
See also: Breast

The basic components of a mature mammary gland are the alveoli (hollow cavities, a few millimeters large), which are lined with milk-secreting cuboidal cells and surrounded by myoepithelial cells. These alveoli join to form groups known as lobules. Each lobule has a lactiferous duct that drains into openings in the nipple. The myoepithelial cells contract under the stimulation of oxytocin, excreting the milk secreted by alveolar units into the lobule lumen toward the nipple. As the infant begins to suck, the oxytocin-mediated "let down reflex" ensues, and the mother's milk is secreted—not sucked—from the gland into the infant's mouth.[4]

All the milk-secreting tissue leading to a single lactiferous duct is collectively called a "simple mammary gland"; in a "complex mammary gland", all the simple mammary glands serve one nipple. Humans normally have two complex mammary glands, one in each breast, and each complex mammary gland consists of 10–20 simple glands. The opening of each simple gland on the surface of the nipple is called a "pore."[5] The presence of more than two nipples is known as polythelia and the presence of more than two complex mammary glands as polymastia.

Maintaining the correct polarized morphology of the lactiferous duct tree requires another essential component – mammary epithelial cells extracellular matrix (ECM) which, together with adipocytes, fibroblast, inflammatory cells, and others, constitute mammary stroma.[6] Mammary epithelial ECM mainly contains myoepithelial basement membrane and the connective tissue. They not only help to support mammary basic structure, but also serve as a communicating bridge between mammary epithelia and their local and global environment throughout this organ's development.[7][8]

Histology

[edit]
Normal histology of the breast
Light micrograph of a human proliferating mammary gland during estrous cycle. Sprouting gland tissue can be seen in the upper left field (haematoxylin eosin staining).

A mammary gland is a specific type of apocrine gland specialized for manufacture of colostrum (first milk) when giving birth. Mammary glands can be identified as apocrine because they exhibit striking "decapitation" secretion. Many sources assert that mammary glands are modified sweat glands.[9][10][11]

Development

[edit]
Further information: Breast development and Parathyroid hormone-related protein

Mammary glands develop during different growth cycles. They exist in both sexes during the embryonic stage, forming only a rudimentary duct tree at birth. In this stage, mammary gland development depends on systemic (and maternal) hormones,[6] but is also under the (local) regulation of paracrine communication between neighboring epithelial and mesenchymal cells by parathyroid hormone-related protein (PTHrP).[12] This locally secreted factor gives rise to a series of outside-in and inside-out positive feedback between these two types of cells, so that mammary bud epithelial cells can proliferate and sprout down into the mesenchymal layer until they reach the fat pad to begin the first round of branching.[6] At the same time, the embryonic mesenchymal cells around the epithelial bud receive secreting factors activated by PTHrP, such as BMP4. These mesenchymal cells can transform into a dense, mammary-specific mesenchyme, which later develop into connective tissue with fibrous threads, forming blood vessels and the lymph system.[13] A basement membrane, mainly containing laminin and collagen, formed afterward by differentiated myoepithelial cells, keeps the polarity of this primary duct tree. These components of the extracellular matrix are strong determinants of duct morphogenesis.[14]

Biochemistry

[edit]

Estrogen and growth hormone (GH) are essential for the ductal component of mammary gland development, and act synergistically to mediate it.[15][16][17][18][19] Neither estrogen nor GH are capable of inducing ductal development without the other.[16][17][18][19] The role of GH in ductal development has been found to be mostly mediated by its induction of the secretion of insulin-like growth factor 1 (IGF-1), which occurs both systemically (mainly originating from the liver) and locally in the mammary fat pad through activation of the growth hormone receptor (GHR).[16][17][18][19][20] However, GH itself also acts independently of IGF-1 to stimulate ductal development by upregulating estrogen receptor (ER) expression in mammary gland tissue, which is a downstream effect of mammary gland GHR activation.[19] In any case, unlike IGF-1, GH itself is not essential for mammary gland development, and IGF-1 in conjunction with estrogen can induce normal mammary gland development without the presence of GH.[19] In addition to IGF-1, other paracrine growth factors such as epidermal growth factor (EGF), transforming growth factor beta (TGF-β),[21] amphiregulin,[22] fibroblast growth factor (FGF), and hepatocyte growth factor (HGF)[23] are involved in breast development as mediators downstream to sex hormones and GH/IGF-1.[24][25][26]

During embryonic development, IGF-1 levels are low, and gradually increase from birth to puberty.[27] At puberty, the levels of GH and IGF-1 reach their highest levels in life and estrogen begins to be secreted in high amounts in females, which is when ductal development mostly takes place.[27] Under the influence of estrogen, stromal and fat tissue surrounding the ductal system in the mammary glands also grows.[28] After puberty, GH and IGF-1 levels progressively decrease, which limits further development until pregnancy, if it occurs.[27] During pregnancy, progesterone and prolactin are essential for mediating lobuloalveolar development in estrogen-primed mammary gland tissue, which occurs in preparation of lactation and nursing.[15][29]

Androgens such as testosterone inhibit estrogen-mediated mammary gland development (e.g., by reducing local ER expression) through activation of androgen receptors expressed in mammary gland tissue,[29][30] and in conjunction with relatively low estrogen levels, are the cause of the lack of developed mammary glands in males.[31]

Timeline

[edit]

Before birth

[edit]

Mammary gland development is characterized by the unique process by which the epithelium invades the stroma. The development of the mammary gland occurs mainly after birth. During puberty, tubule formation is coupled with branching morphogenesis which establishes the basic arboreal network of ducts emanating from the nipple.[32]

Developmentally, mammary gland epithelium is constantly produced and maintained by rare epithelial cells, dubbed as mammary progenitors which are ultimately thought to be derived from tissue-resident stem cells.[33]

Embryonic mammary gland development can be divided into a series of specific stages. Initially, the formation of the milk lines that run between the fore and hind limbs bilaterally on each side of the midline occurs around embryonic day 10.5 (E10.5). The second stage occurs at E11.5 when placode formation begins along the mammary milk line. This will eventually give rise to the nipple. Lastly, the third stage occurs at E12.5 and involves the invagination of cells within the placode into the mesenchyme, leading to a mammary anlage (biology).[34]

The primitive (stem) cells are detected in embryo and their numbers increase steadily during development[35]

Growth

[edit]

Postnatally, the mammary ducts elongate into the mammary fat pad. Then, starting around four weeks of age, mammary ductal growth increases significantly with the ducts invading towards the lymph node. Terminal end buds, the highly proliferative structures found at the tips of the invading ducts, expand and increase greatly during this stage. This developmental period is characterized by the emergence of the terminal end buds and lasts until an age of about 7–8 weeks.

By the pubertal stage, the mammary ducts have invaded to the end of the mammary fat pad. At this point, the terminal end buds become less proliferative and decrease in size. Side branches form from the primary ducts and begin to fill the mammary fat pad. Ductal development decreases with the arrival of sexual maturity and undergoes estrous cycles (proestrus, estrus, metestrus, and diestrus). As a result of estrous cycling, the mammary gland undergoes dynamic changes where cells proliferate and then regress in an ordered fashion.[36]

Pregnancy

[edit]

During pregnancy, the ductal systems undergo rapid proliferation and form alveolar structures within the branches to be used for milk production. After delivery, lactation occurs within the mammary gland; lactation involves the secretion of milk by the luminal cells in the alveoli. Contraction of the myoepithelial cells surrounding the alveoli will cause the milk to be ejected through the ducts and into the nipple for the nursing infant. Upon weaning of the infant, lactation stops and the mammary gland turns in on itself, a process called involution. This process involves the controlled collapse of mammary epithelial cells where cells begin apoptosis in a controlled manner, reverting the mammary gland back to a pubertal state.

Postmenopausal

[edit]

During postmenopause, due to much lower levels of estrogen, and due to lower levels of GH and IGF-1, which decrease with age, mammary gland tissue atrophies and the mammary glands become smaller.

Physiology

[edit]

Hormonal control

[edit]

Lactiferous duct development occurs in females in response to circulating hormones. First development is frequently seen during pre- and postnatal stages, and later during puberty. Estrogen promotes branching differentiation,[37] whereas in males testosterone inhibits it. A mature duct tree reaching the limit of the fat pad of the mammary gland comes into being by bifurcation of duct terminal end buds (TEB), secondary branches sprouting from primary ducts[7][38] and proper duct lumen formation. These processes are tightly modulated by components of mammary epithelial ECM interacting with systemic hormones and local secreting factors. However, for each mechanism the epithelial cells' "niche" can be delicately unique with different membrane receptor profiles and basement membrane thickness from specific branching area to area, so as to regulate cell growth or differentiation sub-locally.[39] Important players include beta-1 integrin, epidermal growth factor receptor (EGFR), laminin-1/5, collagen-IV, matrix metalloproteinase (MMPs), heparan sulfate proteoglycans, and others. Elevated circulating level of growth hormone and estrogen get to multipotent cap cells on TEB tips through a thin, leaky layer of basement membrane. These hormones promote specific gene expression. Hence cap cells can differentiate into myoepithelial and luminal (duct) epithelial cells, and the increased amount of activated MMPs can degrade surrounding ECM helping duct buds to reach further in the fat pads.[40][41] On the other hand, basement membrane along the mature mammary ducts is thicker, with strong adhesion to epithelial cells via binding to integrin and non-integrin receptors. When side branches develop, it is a much more "pushing-forward" working process including extending through myoepithelial cells, degrading basement membrane and then invading into a periductal layer of fibrous stromal tissue.[7] Degraded basement membrane fragments (laminin-5) roles to lead the way of mammary epithelial cells migration.[42] Whereas, laminin-1 interacts with non-integrin receptor dystroglycan negatively regulates this side branching process in case of cancer.[43] These complex "Yin-yang" balancing crosstalks between mammary ECM and epithelial cells "instruct" healthy mammary gland development until adult.

There is preliminary evidence that soybean intake mildly stimulates the breast glands in pre- and postmenopausal women.[44]

Pregnancy

[edit]

Secretory alveoli develop mainly in pregnancy, when rising levels of prolactin, estrogen, and progesterone cause further branching, together with an increase in adipose tissue and a richer blood flow. In gestation, serum progesterone remains at a stably high concentration so signaling through its receptor is continuously activated. As one of the transcribed genes, Wnts secreted from mammary epithelial cells act paracrinely to induce more neighboring cells' branching.[45][46] When the lactiferous duct tree is almost ready, "leaves" alveoli are differentiated from luminal epithelial cells and added at the end of each branch. In late pregnancy and for the first few days after giving birth, colostrum is secreted. Milk secretion (lactation) begins a few days later due to reduction in circulating progesterone and the presence of another important hormone prolactin, which mediates further alveologenesis, milk protein production, and regulates osmotic balance and tight junction function. Laminin and collagen in myoepithelial basement membrane interacting with beta-1 integrin on epithelial surface again, is essential in this process.[47][48] Their binding ensures correct placement of prolactin receptors on the basal lateral side of alveoli cells and directional secretion of milk into lactiferous ducts.[47][48] Suckling of the baby causes release of the hormone oxytocin, which stimulates contraction of the myoepithelial cells. In this combined control from ECM and systemic hormones, milk secretion can be reciprocally amplified so as to provide enough nutrition for the baby.

Weaning

[edit]

During weaning, decreased prolactin, missing mechanical stimulation (baby suckling), and changes in osmotic balance caused by milk stasis and leaking of tight junctions cause cessation of milk production. It is the (passive) process of a child or animal ceasing to be dependent on the mother for nourishment. In some species there is complete or partial involution of alveolar structures after weaning, in humans there is only partial involution and the level of involution in humans appears to be highly individual. The glands in the breast do secrete fluid also in nonlactating women.[49] In some other species (such as cows), all alveoli and secretory duct structures collapse by programmed cell death (apoptosis) and autophagy for lack of growth promoting factors either from the ECM or circulating hormones.[50][51] At the same time, apoptosis of blood capillary endothelial cells speeds up the regression of lactation ductal beds. Shrinkage of the mammary duct tree and ECM remodeling by various proteinase is under the control of somatostatin and other growth inhibiting hormones and local factors.[52] This major structural change leads loose fat tissue to fill the empty space afterward. But a functional lactiferous duct tree can be formed again when a female is pregnant again.

Clinical significance

[edit]

Tumorigenesis in mammary glands can be induced biochemically by abnormal expression level of circulating hormones or local ECM components,[53] or from a mechanical change in the tension of mammary stroma.[54] Under either of the two circumstances, mammary epithelial cells would grow out of control and eventually result in cancer. Almost all instances of breast cancer originate in the lobules or ducts of the mammary glands.

Other mammals

[edit]

General

[edit]

The breasts of female humans vary from most other mammals that tend to have less conspicuous mammary glands. The number and positioning of mammary glands varies widely in different mammals. The protruding teats and accompanying glands can be located anywhere along the two milk lines. In general most mammals develop mammary glands in pairs along these lines, with a number approximating the number of young typically birthed at a time. The number of teats varies from 2 (in most primates) to 18 (in pigs). The Virginia opossum has 13, one of the few mammals with an odd number.[55][56] The following table lists the number and position of teats and glands found in a range of mammals:

Species[57] Anterior
(thoracic) 		Intermediate
(abdominal) 		Posterior
(inguinal) 		Total
Goat, sheep, horse
guinea pig 		0 0 2 2
Cattle 0 0 4 4
Cat 2 2 4 8
Dog[58] 4 2 2 or 4 8 or 10
Mouse 6 0 4 10
Rat 6 2 4 12
Pig 6 6 6 18
Proboscideans, primates 2 0 0 2
Virginia opossum[55][56] 0 0 13 13
Southern red-sided opossum[59] 0 0 25 to 27 25 to 27

Male mammals typically have rudimentary mammary glands and nipples, with a few exceptions: male mice do not have nipples,[60] male marsupials do not have mammary glands,[61] and male horses lack nipples.[62] The male dayak fruit bat has lactating mammary glands.[63] Male lactation occurs infrequently in some species.[64]

Mammary glands are true protein factories,[65] and several labs have constructed transgenic animals, mainly goats and cows, to produce proteins for pharmaceutical use.[66] Complex glycoproteins such as monoclonal antibodies or antithrombin cannot be produced by genetically engineered bacteria, and the production in live mammals is much cheaper than the use of mammalian cell cultures.

Evolution

[edit]

There are many theories on how mammary glands evolved. For example, it is thought that the mammary gland is a transformed sweat gland, more closely related to apocrine sweat glands.[67] Because mammary glands do not fossilize well, supporting such theories with fossil evidence is difficult. Many of the current theories are based on comparisons between lines of living mammals—monotremes, marsupials, and eutherians. One theory proposes that mammary glands evolved from glands that were used to keep the eggs of early mammals moist[68][69] and free from infection[70][71] (monotremes still lay eggs). Other theories suggest that early secretions were used directly by hatched young,[72] or that the secretions were used by young to help them orient to their mothers.[73]

Lactation is thought to have developed long before the evolution of the mammary gland and mammals; see evolution of lactation.

Additional images

[edit]

See also

[edit]
This article uses anatomical terminology.

List of distinct cell types in the adult human body

References

[edit]

Bibliography

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Mammary gland

View on Grokipedia
from Grokipedia
The mammary gland is a specialized, compound tubuloalveolar structure unique to mammals, serving as the primary organ for production and secretion to nourish offspring postnatally. Functionally, it consists of modified sweat glands that develop into glandular tissue capable of synthesizing and delivering , ensuring across mammalian . In humans, the mammary glands are paired structures located on the anterior chest wall, overlying the pectoralis major muscles and extending from the second to sixth , with more pronounced development in after . Structurally, each mammary gland comprises 15 to 20 lobes of glandular tissue arranged radially around the , connected by a network of ducts that converge at the nipple's surface for ejection. These lobes are supported by , including for shape maintenance, and interspersed with that varies by age, hormonal status, and . The and contain fibers and endings, facilitating both and tactile sensitivity, while Montgomery's glands in the areola provide lubrication during . Development of the mammary gland begins as epidermal thickenings, with significant growth occurring during under and progesterone influence, leading to ductal elongation and fat deposition in females. In males, testosterone suppresses further development, resulting in rudimentary glands without functional lobules. During , and other hormones induce lobuloalveolar proliferation, preparing the gland for ; post-delivery, oxytocin triggers milk let-down via contraction around alveoli. This hormonal regulation underscores the gland's dynamic physiology, adapting to reproductive stages while also playing roles in due to its dense innervation.

Anatomy and Structure

Gross anatomy

The mammary glands are paired structures situated in the of the anterior chest wall within the pectoral region, overlying the muscle and extending from the second to the sixth , laterally to the mid-axillary line. In females, these glands are well-developed and functional for , while in males, they remain rudimentary and non-functional. The size and shape of the breasts vary considerably among individuals, primarily influenced by the amount of , with the remainder consisting of glandular and in varying proportions depending on age, hormonal status, and . Internally, each mammary gland is divided into 15-20 lobes of glandular tissue arranged in a radial fashion around the , separated by fibrous septa known as , which provide structural support and extend from the to the deep pectoral . Each lobe comprises multiple lobules connected by intralobular ducts that converge to form a major , with the 15-20 lactiferous ducts widening into sinuses before opening independently on the 's surface. The nipple-areola complex forms the external apex of the gland; the is a protruding cylindrical structure approximately 0.5-1.3 cm long containing the duct orifices, surrounded by the , a 3-6 cm diameter pigmented area rich in fibers and sebaceous Montgomery's glands that secrete lubricating oils to protect the during . The arterial supply to the mammary gland arises primarily from the through its perforating branches (supplying the medial aspect from the 2nd to 4th intercostal spaces), supplemented by the (lateral aspect) and lateral branches of the posterior . Venous drainage parallels the arterial supply, with superficial veins forming networks beneath the skin that drain into the internal thoracic and axillary veins, while deeper veins accompany the arteries. Lymphatic drainage is crucial for immune surveillance and occurs mainly to the (accounting for 75% of flow, via anterior/pectoral, posterior/subscapular, lateral, and central groups), with the remainder directed to internal mammary (parasternal) nodes and a minor portion to supraclavicular nodes; lateral breast quadrants drain predominantly to axillary nodes, while medial quadrants favor internal mammary pathways. Sensory innervation of the mammary gland derives from the anterior and lateral cutaneous branches of the 2nd through 6th (T2-T6), providing dermatomal coverage, along with medial contributions from (C3-C4). The and receive dense innervation from the 4th intercostal nerve, enhancing tactile sensitivity essential for the milk ejection during . Anatomical variations in the mammary gland are common and include bilateral asymmetry in breast size and shape, observed in up to 50% of women to some degree, often due to differences in glandular and adipose content. Supernumerary nipples (polythelia) occur in 1-6% of the population, typically as small, pigmented spots along the embryonic milk line extending from the axilla to the inguinal region, resulting from incomplete regression of the . Accessory breast tissue (polymastia) is rarer, affecting 0.4-6% of individuals, and manifests as ectopic glandular tissue, most frequently in the axillary region, which may enlarge during or .

Histology

The mammary gland consists of a complex tubuloalveolar structure composed of epithelial and stromal components, forming a modified specialized for production. The epithelial layer is organized as a bilayer, with an inner luminal lining the ducts and alveoli, and an outer basal layer of myoepithelial cells resting on a . Epithelial components include cuboidal to columnar luminal cells that form the lining of ducts and alveoli, responsible for , while myoepithelial cells, which are contractile and star-shaped, surround these structures to facilitate milk ejection. The , a thin acellular layer of , separates the from the underlying stroma, providing structural support and regulating cell interactions. Stromal elements comprise , which predominates in the non-lactating gland and provides bulk, along with fibrous consisting of dense irregular fibers that form interlobular septa separating glandular lobules. Immune cells, such as macrophages, are present within the intralobular stroma, contributing to tissue and defense. Glandular units are organized into lobules containing alveoli—spherical, milk-producing sacs lined by epithelial cells with apical secretory vesicles for and protein components—and connected by intralobular ducts that converge into larger lactiferous ducts and sinuses near the . These units are embedded in stroma. During the , the mammary gland exhibits mild histologic changes; in the proliferative phase, ductal elongation and epithelial proliferation occur, while in the secretory phase, alveolar budding and increased epithelial height are observed, reflecting and progesterone influences. Special features include mammary stem cells located in the basal layer, which enable tissue regeneration and maintenance through self-renewal and differentiation capabilities. The surrounding the features with melanocytes responsible for its pigmentation, varying by individual and potentially darkening during hormonal shifts.

Development

Embryonic and fetal development

The development of the mammary gland begins in the early embryonic period, originating from the al mammary ridges, also known as milk lines, which appear around weeks 4 to 6 of gestation. These ridges form as bilateral thickenings of the surface extending from the to the inguinal region, but in humans, only the paired thoracic thickenings persist and develop into mammary primordia, while others regress. The budding process initiates with the formation of the primary by approximately week 6, where the ectodermal placode thickens and protrudes into the underlying . This is followed by the development of a secondary around weeks 8 to 10, characterized by of the epithelial deeper into the mammary , establishing the initial epithelial-mesenchymal interactions essential for further . Sexual differentiation of the mammary primordia occurs early, with initial development being independent of sex steroids in both males and females up to around week 9. In male fetuses, exposure to androgens from the testes leads to regression of the mammary buds, preventing further growth, whereas in females, the absence of androgens allows continued development without significant estrogen influence at this stage. During fetal life, key milestones include the onset of branching around week 12, where the primary duct begins to elongate and branch within the mammary fat pad precursor. formation occurs by week 16 through mesenchymal and epidermal , and by birth, a basic ductal framework consisting of 15-25 short ducts is established, embedded in , setting the stage for postnatal expansion. Genetic factors play a critical role in mammary ridge specification and bud formation, with signaling pathways such as Wnt (particularly Wnt10b) regulating placode induction and maintenance along the , fibroblast growth factors (FGFs, including ) promoting bud outgrowth and invagination, and (e.g., Hoxc6 and Hoxc8) contributing to the anterior-posterior positioning and patterning of the ridges.

Postnatal development

Following birth, the mammary glands enter a dormant phase during infancy and childhood, characterized by minimal growth and the maintenance of rudimentary ductal structures established prenatally. In newborns, transient glandular activity may occur due to maternal hormones, but this subsides rapidly, leaving the gland quiescent with sparse epithelial structures embedded in minimal . Throughout childhood, the mammary gland exhibits little proliferation, serving primarily as a of undifferentiated epithelial cells within a that slowly expands with overall body growth. Pubertal development marks the primary phase of postnatal mammary gland maturation in females, initiated by rising levels of ovarian hormones around ages 8 to 13. , the onset of breast budding, represents the first visible sign and is driven by , which induces ductal elongation, branching morphogenesis, and stromal fat deposition to form the foundational architecture of the gland. This progression is classically described by the Tanner stages: stage 1 denotes the prepubertal flat contour; stage 2 involves with breast bud formation under the areola; stages 3 and 4 feature further enlargement and areolar separation; and stage 5 achieves mature contour by mid-to-late . Growth factors such as (IGF-1), stimulated by , and play key roles in promoting epithelial proliferation and ductal branching during this period. In males, postnatal mammary gland development remains limited, with persistence of basic ductal remnants but without significant lobular formation or accumulation, largely due to the inhibitory effects of androgens like testosterone on estrogen-driven growth. By the late teens, the ductal reaches completion, forming a fully arborized network that spans the gland, accompanied by minimal development of alveolar precursors poised for future reproductive demands.

Changes during pregnancy and lactation

During , the mammary gland experiences profound structural remodeling to establish a functional secretory apparatus. In the early phase, particularly the first trimester, and stimulate ductal proliferation and branching, extending the existing ductal network from and initiating the formation of alveolar buds. This prepares the gland for subsequent expansion, with rapid increases in ductal length and side-branching observed in models as proxies for development. By the mid-to-late (second and third trimesters), progesterone synergizes with to drive lobuloalveolar development, promoting extensive tertiary branching, alveolar budding, and differentiation into secretory lobules capable of production. These changes result in a significant increase in volume, on average about 96 ml, due to epithelial and stromal expansion. At parturition, the withdrawal of placental progesterone triggers lactogenesis, marking the onset of . The mammary initially secretes , a nutrient-dense fluid rich in immunoglobulins, for the first 2-5 days postpartum. This transitions to mature milk by approximately days 3-5, as alveolar epithelial cells fully activate secretory pathways, with milk volume increasing from milliliters to hundreds of milliliters daily. Structural adaptations during this phase include further alveolar distension and epithelial , where cuboidal cells enlarge and polarize to facilitate and . Throughout active , the mammary gland expands dramatically to sustain output. Alveolar clusters proliferate in number and size, forming dense lobuloalveolar arrays that occupy much of the adipose stroma, accompanied by enhanced vascularization to meet the heightened metabolic demands— can increase up to threefold in murine models during this period. Epithelial cells undergo , accumulating intracellular droplets for synthesis and forming micelles within Golgi-derived vesicles for protein export, enabling the gland to produce approximately 750-1000 mL of daily at peak. Peak structural and functional maturity typically occurs 3-6 months postpartum, coinciding with maximal yield before gradual adaptations to demands. Upon , the mammary gland initiates reversible changes, with reduced suckling leading to milk stasis, alveolar collapse, and partial epithelial regression through , restoring much of the pre-pregnancy architecture while retaining some proliferative capacity for future cycles. This initial involution is hormonally modulated by decline and does not fully eliminate the expanded ductal framework.

Involution and postmenopausal changes

Following , the mammary gland undergoes post-lactation involution, a process characterized by the () of secretory alveoli, which largely completes within 2-4 weeks. This regression is primarily mediated by transforming growth factor-β (TGF-β), which promotes epithelial and tissue remodeling while suppressing signals. The result is a partial restoration of the pre-pregnancy state, with significant reduction in glandular volume but retention of some ductal structures. During menopause, typically beginning around ages 45-55, declining levels trigger further mammary gland changes, including the replacement of glandular tissue with , ductal , and increased . This estrogen withdrawal leads to shrinkage of the secretory lobules and overall reduction in breast density, altering the gland's composition toward a more fatty profile. Fibrotic changes contribute to tissue stiffening, reflecting remodeling in response to hormonal shifts. Age-related alterations in the mammary gland include reduced elasticity due to cross-linking in the stroma, which begins notably after age 25 and accelerates post-menopause. In males, equivalent mammary glands exhibit minimal age-related changes, remaining largely undeveloped and quiescent without the proliferative demands of or cyclical hormones. Long-term outcomes of mammary involution and aging involve , marked by shortened telomeres in epithelial cells, which limit replicative capacity and contribute to tissue homeostasis decline. These senescence-associated changes accumulate over decades, promoting a pro-inflammatory microenvironment. In cases of incomplete regression, persistent lobular tissue post-involution or post-menopause is associated with increased susceptibility, as it maintains a proliferative epithelial compartment vulnerable to oncogenic transformation.

Physiology

Hormonal control

The development, , and function of the mammary gland are orchestrated by an intricate network of hormones primarily from the hypothalamic-pituitary-gonadal axis, as well as placental and other endocrine sources, ensuring coordination with reproductive cycles and offspring needs. Key hormones include , which primarily drives ductal elongation and branching during ; progesterone, which stimulates alveolar bud formation and lobuloalveolar development during ; , essential for epithelial and subsequent milk protein synthesis; oxytocin, responsible for myoepithelial contraction during milk ejection; and along with (IGF-1), which exert synergistic effects to amplify the actions of hormones on tissue growth. These hormonal influences are conserved across mammals, with similar mechanisms observed in humans, though species-specific variations exist in sensitivity and timing. Hormonal regulation varies across life stages to align mammary gland maturation with reproductive demands. During , a surge in production, triggered by the of the hypothalamic-pituitary-gonadal axis, initiates and sustains ductal morphogenesis in the mammary fat pad. In , rising levels of progesterone, supported by placental hormones such as , promote the proliferation and differentiation of alveolar structures, preparing the gland for . Postpartum, the suckling reflex inhibits release from the , leading to elevated levels that sustain synthesis and glandular maintenance until . Feedback mechanisms fine-tune hormonal activity to prevent dysregulation. A primary negative feedback loop involves , which tonically inhibits secretion from the ; reduced signaling during allows surges, while its restoration post-weaning suppresses . Additionally, and other hormones exhibit circadian rhythms, with peak levels often occurring at night, influencing daily patterns of mammary activity in lactating individuals. Pathophysiologically, elevated levels, or hyperprolactinemia, can disrupt normal regulation by inducing premature or persistent glandular proliferation and independent of .

Lactogenesis and milk production

Lactogenesis occurs in two distinct stages, marking the transition from mammary gland preparation to active milk production. Stage I, also known as secretory , begins in the second half of and involves autocrine mechanisms that prepare mammary epithelial cells for milk synthesis, including the differentiation of alveoli and the onset of production despite high progesterone levels from the . This stage is characterized by the gland becoming competent to secrete milk components like low levels of and proteins, driven by local factors within the mammary tissue. Stage II, or secretory activation, is triggered post-delivery by an endocrine switch involving a surge in and a sharp decline in progesterone, leading to the abrupt onset of copious typically within 40-72 hours after birth. Hormonal triggers, such as those detailed in endocrine regulation, initiate these changes in alveolar structure during late . Human milk composition varies by lactation stage but primarily consists of macronutrients tailored for infant nutrition. The primary carbohydrate is lactose, synthesized via glucose uptake into mammary epithelial cells, providing about 7% of milk's weight and serving as an osmotic driver for milk volume. Lipids, comprising 3-5% of mature milk, are mainly triglycerides produced through de novo synthesis in the endoplasmic reticulum and Golgi apparatus, with colostrum containing lower fat levels (around 2-3%). Proteins make up 0.8-1.2% of the total, including caseins (about 40% of proteins) that form micelles for calcium transport and whey proteins like alpha-lactalbumin, which supports lactose synthesis; colostrum is richer in proteins (2-3%) for immune support. Micronutrients include vitamins (e.g., A, D, E) and minerals (e.g., calcium, iron), with colostrum notably high in immunoglobulins such as IgA for . At the cellular level, milk synthesis and secretion occur in the alveolar epithelial cells through specialized mechanisms. Lactose is produced in the Golgi apparatus via the lactose synthase complex, which catalyzes the reaction: UDP-galactose+glucose→lactose+UDP\text{UDP-galactose} + \text{glucose} \rightarrow \text{lactose} + \text{UDP} This process, involving alpha-lactalbumin and galactosyltransferase, draws water into secretory vesicles, expanding milk volume. Proteins and water-soluble components are secreted merocrine-style via exocytosis of Golgi-derived vesicles into the alveolar lumen, while lipids are released through apocrine secretion, where cytoplasmic crescents containing fat globules are pinched off from the apical membrane without cell death. The Golgi apparatus plays a central role in packaging these components into vesicles for transport and secretion. Milk production is locally regulated by the feedback inhibitor of (FIL), a that accumulates in the alveolar lumen during engorgement and inhibits further synthesis by binding to receptors on epithelial cells, reducing rates. This autocrine mechanism ensures production matches demand, with removal of diluting FIL and restoring synthesis. In well-nourished mothers, daily milk output typically ranges from 500 to 1000 mL after the first week postpartum, stabilizing around 750-800 mL by one month, with variations influenced by maternal , such as higher yields in women with adequate caloric intake.

Milk ejection and weaning

The milk ejection reflex, also known as the let-down reflex, is a neuroendocrine response triggered by nipple stimulation during suckling, leading to the release of oxytocin from the gland. This hormone binds to receptors on myoepithelial cells surrounding the mammary alveoli, causing their contraction and the subsequent dilation of milk ducts, which propels toward the nipple for infant consumption. The process ensures efficient milk transfer, with each suckling episode typically eliciting multiple pulses of oxytocin release to facilitate repeated ejections during a single feeding session. The underlying this involves afferent signals from mechanoreceptors in the and , transmitted via the T4-T6 and dorsal roots to the , and ascending to the . Within the , these signals stimulate oxytocinergic neurons in the supraoptic and paraventricular nuclei, which project to the for release into the bloodstream. Over the initial days of , the becomes conditioned, allowing triggers beyond direct suckling—such as hearing the infant cry or even thinking about the baby—to elicit oxytocin release, typically within seconds to minutes of stimulation. Stress can inhibit the milk ejection reflex through elevated cortisol levels, which interfere with oxytocin release by activating the hypothalamic-pituitary-adrenal axis and suppressing hypothalamic signaling. This interference often manifests as delayed or absent let-down, reducing milk flow and potentially leading to inadequate feeding for the , though interventions like relaxation techniques can mitigate the effect by lowering . Weaning marks the transition from to the cessation of production, typically initiated by a gradual reduction in suckling frequency, which decreases secretion from the and halts ongoing synthesis. This suppression, combined with stasis in the alveoli, triggers the onset of mammary gland involution, a remodeling process that restores the gland to a pre-pregnancy state through epithelial cell and tissue resorption. In cases of abrupt , psychological factors such as maternal guilt, anxiety, or emotional distress can exacerbate the process, potentially prolonging discomfort or influencing hormonal recovery. Human infants are generally recommended to receive exclusive for the first 6 months, with continued up to 1-2 years or beyond, leading to full around 6-12 months in many populations, though timing varies by cultural and individual factors.

Clinical Significance

Common disorders

Mastitis is an inflammatory condition of the mammary gland, most commonly occurring as lactational mastitis in breastfeeding women due to bacterial infection, typically Staphylococcus aureus entering through cracked nipples or from the infant's mouth. Symptoms include localized breast pain, redness, swelling, and systemic signs such as fever and flu-like malaise; if untreated, it may progress to abscess formation requiring drainage. Treatment involves a 10- to 14-day course of antibiotics like dicloxacillin or cephalexin, continued breastfeeding or pumping to promote drainage, and supportive measures such as warm compresses and analgesics. It affects approximately 20% of breastfeeding women, with risk factors including incomplete milk emptying and suboptimal breastfeeding technique. Fibrocystic changes represent the most common benign alteration in the mammary gland, characterized by hormonally influenced lumpy or nodular tissue, often accompanied by cyclical that worsens premenstrually due to and progesterone fluctuations. These changes manifest as diffuse tenderness, palpable cysts, or thickening, typically in women of reproductive age, and are not associated with increased cancer risk. Prevalence is high, with up to 50% of women experiencing symptomatic episodes during their lifetime, though lifetime occurrence may reach 70-90%. Management focuses on symptom relief through supportive bras, analgesics like ibuprofen, and hormonal contraceptives if severe; may be used for dominant cysts. Galactorrhea refers to inappropriate milky discharge from the mammary glands unrelated to or , often resulting from hyperprolactinemia caused by pituitary adenomas, medications (e.g., antipsychotics, antidepressants), or . It may present unilaterally or bilaterally with spontaneous nipple leakage, and underlying causes require exclusion of physiologic stimuli like nipple manipulation. Diagnostic workup includes serum measurement, , exclusion, and MRI of the pituitary if prolactin is elevated; medication review is essential. Treatment targets the etiology, such as dopamine agonists (e.g., ) for prolactinomas or discontinuing offending drugs. Nipple disorders encompass several benign conditions affecting the nipple-areolar complex, including congenital inversion, cracks, and inflammatory mimics of more serious pathologies. Congenital nipple inversion, present in up to 10% of women, arises from short lactiferous ducts or tethering bands during development and is graded by eversibility (grade 1 easily everted, grade 3 fixed); it is typically bilateral and familial but may complicate breastfeeding. Nipple cracks commonly occur in early lactation due to poor latch or dry skin, causing pain and bleeding, and increase infection risk; prevention involves correct positioning, while treatment includes lanolin application and hydrogel dressings. Non-cancerous conditions mimicking Paget's disease, such as eczema or contact dermatitis, present with erythematous, scaly, or crusty nipple changes from irritants or atopy, resolved with topical steroids after biopsy to rule out malignancy. Other common issues include blocked milk ducts, engorgement, and mastalgia, which often arise during or hormonal cycles. Blocked ducts, resulting from incomplete emptying, cause tender, localized lumps and may precede if unresolved; massage and frequent feeding typically suffice. Postpartum engorgement, due to vascular and lymphatic congestion around days 3-5, affects 20-77% of women with swollen, painful , managed by cold compresses, leaves, and pumping. Mastalgia, or , impacts up to 70% of women, mostly cyclically from hormonal sensitivity, and is treated with reassurance, evening primrose oil, or low-dose in refractory cases.

Disorders in males

Gynecomastia, the benign enlargement of breast tissue in males due to hormonal imbalance, affects 35-70% of men at some point, often during , aging, or due to medications, , or . It is usually self-limiting but may require evaluation to exclude underlying pathology or malignancy; treatment includes addressing causes, reassurance, or surgery in persistent cases. is rare, with a lifetime of about 1 in 1,000 men, presenting similarly to female cases but often at advanced stages due to delayed diagnosis.

Breast cancer and other malignancies

Breast cancer is the most common malignancy affecting women worldwide, with an estimated lifetime risk of approximately 13% or 1 in 8 women in the United States. It arises from the epithelial cells of the mammary gland ducts or lobules and is primarily an adenocarcinoma in histological classification. Key risk factors include female sex, advancing age, inherited genetic mutations such as BRCA1 and BRCA2, family history of the disease, and prolonged exposure to endogenous or exogenous hormones, such as through hormone replacement therapy. These factors contribute to the etiology by promoting uncontrolled cell proliferation in the breast tissue, often influenced by hormonal signaling pathways. The main types of breast cancer include ductal carcinoma in situ (DCIS), a non-invasive form confined to the milk ducts, and invasive carcinomas, which account for the majority of cases. Invasive ductal carcinoma, the most prevalent subtype comprising about 80% of invasive cases, originates in the ducts and exhibits adenocarcinoma histology with glandular differentiation. Invasive lobular carcinoma, representing 10-15% of cases, arises from the lobules and is characterized by cells that lack cohesion due to loss of E-cadherin expression. Molecular subtypes further classify these based on receptor status: hormone receptor-positive (HR+, including estrogen receptor [ER] and/or progesterone receptor [PR] positive, often HER2-negative, known as luminal A or B), HER2-enriched (HR-negative, HER2-positive), and triple-negative (lacking ER, PR, and HER2, associated with more aggressive behavior). Other malignancies of the mammary gland are rare and include primary sarcomas, which arise from stromal and account for less than 1% of breast cancers; lymphomas, typically non-Hodgkin types involving lymphoid tissue; and phyllodes tumors, which can exhibit malignant behavior in about 10-20% of cases with stromal overgrowth and high mitotic activity. These differ from epithelial carcinomas in origin and are managed differently, often requiring specialized review. Breast cancer is staged using the TNM system, which assesses tumor size (T), regional involvement (N), and distant (M). Axillary status is a critical prognostic factor, with involvement indicating regional spread; for instance, to 1-3 nodes classifies as N1, while more extensive involvement worsens the stage. Common sites of distant include bones, lungs, liver, and , occurring in advanced stages (III-IV) and significantly impacting survival. Prevention strategies focus on risk reduction, such as lifestyle modifications to address modifiable factors like alcohol consumption and , while screening involves biennial for women aged 40-74 to detect early lesions. for /2 mutations is recommended for individuals with strong family history or personal risk factors to guide preventive measures like enhanced surveillance or prophylactic surgery. Management of breast cancer typically involves multimodal therapy tailored to stage and subtype, including (lumpectomy or ), followed by for local control. Systemic treatments encompass for high-risk or triple-negative cases, such as for HR-positive tumors to block signaling, and targeted therapies like for HER2-positive disease. These approaches have improved five-year survival rates to nearly 100% for localized disease (as of 2025).

Comparative Mammalogy

Structure in other mammals

The mammary glands of monotremes, such as the and echidna, lack true nipples and instead feature a dense cluster of mammo-pilo-sebaceous units that open onto a nipple-less mammary patch on the , where milk is secreted and licked by the young from the fur or a temporary pouch. In marsupials, including and , mammary glands are equipped with multiple teats arranged within a pouch that encloses the nursing young, facilitating attachment and suckling shortly after birth. Among placental mammals, the number and position of mammary glands vary widely to accommodate reproductive strategies: typically have two pectoral glands, dogs possess 8 to 10 along the ventral , and pigs can have over 20 distributed from the chest to the , reflecting adaptations for single (monotocous) versus multiple (polytocous) . Gland positioning in placental mammals often correlates with locomotion and litter size; for instance, many herbivores like and cows have inguinal glands located near the hind limbs for efficient while grazing, whereas carnivores such as cats and dogs feature pectoral or abdominal arrangements that support multiple pups in a environment. In monotocous species like , glands are paired and axillary or inguinal, while polytocous may have up to 12 pairs scattered ventrally to allow simultaneous by large s. Specialized adaptations are evident in aquatic mammals: cetaceans like whales have two mammary glands concealed within mammary slits on the ventral surface for hydrodynamic streamlining, with milk ejection aided by voluntary muscular contractions rather than suckling reflexes. Pinnipeds such as seals exhibit retractable nipples or slits protecting the glands from water and predators, and their mammary tissue contains high fat deposits to produce energy-dense suited for fasting pups on land or ice. In monotremes, milk ejection relies on rhythmic abdominal contractions to express secretions from the pores. Despite these variations, histological features of mammary glands are conserved across mammals, featuring a branched tubuloalveolar structure with alveoli lined by secretory epithelial cells draining into ducts, derived from epidermal glands. This alveolar-ductal organization supports synthesis and transport universally, though fat content in the varies, such as elevated levels in seals to enhance caloric yield. In domestic animals, the bovine exemplifies a specialized inguinal structure comprising four independent quarters, each with a and supported by suspensory ligaments, enabling high-volume production critical for industries. Similarly, the caprine udder in features two smaller glands with elongated teats, adapted for in cheesemaking, while porcine glands support litter nursing in farming contexts.

Evolutionary origins

The mammary gland originated in the synapsid lineage, the ancestral group to mammals, dating back approximately 300 million years ago during the late or early Permian periods. Early synapsids likely possessed proto-mammary glands derived from apocrine-like epidermal glands associated with follicles, which secreted moisture and substances to protect parchment-shelled eggs from in terrestrial environments. These proto-milk secretions, inferred from and the presence of similar glands in modern reptiles, provided essential hydration and immune protection for eggs laid in humid nests, marking an initial adaptive step toward nutrient delivery in amniote reproduction. During the mammalian radiation in the period around 200 million years ago, true emerged alongside and extended , transforming proto-milk into a nutrient-rich fluid that supported developing young post-hatching or birth. This shift correlated with the evolution of live birth in therian mammals (marsupials and placentals), where became crucial for neonatal nutrition and immunity, enhancing offspring survival in diverse ecological niches. Key adaptations included the development of nipples or teats, which concentrated glandular secretions and facilitated efficient suckling by infants, reducing energy loss from scattered skin secretions in earlier synapsid "mammary patches." supports this, with duplications of the gene in therian lineages enabling specialized regulation of mammary development and milk synthesis, distinct from the simpler hormonal controls in monotremes. Direct for mammary glands is scarce due to the soft-tissue of these structures, but inferences are drawn from rare synapsid skin impressions showing epidermal scales and glandular patterns, as well as comparative revealing conserved developmental pathways across mammals. For instance, therapsid fossils exhibit bone and tooth mineralization suggestive of pre-feeding milk nutrients, indicating functional predated modern mammals. stands as a defining synapomorphy of mammals, with ecological variations such as delayed implantation in species like bears and seals allowing mothers to time bursts with seasonal food availability, optimizing energy allocation for offspring in unpredictable environments.

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC8998991/
  2. https://training.seer.cancer.gov/anatomy/reproductive/female/glands.html
  3. https://www.ncbi.nlm.nih.gov/books/NBK547666/
  4. https://my.clevelandclinic.org/health/articles/8330-breast-anatomy
  5. https://pathology.jhu.edu/breast/overview
  6. https://www.ncbi.nlm.nih.gov/books/NBK547732/
  7. https://humananatomy.host.dartmouth.edu/BHA/public_html/part_2/chapter_7.html
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC2234450/
  9. https://pubmed.ncbi.nlm.nih.gov/9213048/
  10. https://pubmed.ncbi.nlm.nih.gov/17521013/
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC3706049/
  12. https://blogs.gwu.edu/smhs-histology/mammary-gland/
  13. https://histology.siu.edu/erg/mammary.htm
  14. https://www.nature.com/articles/3880699
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC6341275/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC3706056/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC2869520/
  18. https://www.sciencedirect.com/science/article/pii/S1084952120302068
  19. https://www.sciencedirect.com/science/article/abs/pii/S1084952112000663
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC3404495/
  21. https://journals.biologists.com/dev/article/135/6/995/65043/Mammary-development-in-the-embryo-and-adult-a
  22. https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr1368
  23. https://www.annualreviews.org/content/journals/10.1146/annurev-animal-031412-103632
  24. https://journals.biologists.com/dev/article/147/22/dev169862/226060/Mammary-development-in-the-embryo-and-adult-new
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC11384216/
  26. https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr1653
  27. https://pubmed.ncbi.nlm.nih.gov/24100511
  28. https://pubmed.ncbi.nlm.nih.gov/32816256/
  29. https://www.ncbi.nlm.nih.gov/books/NBK539790/
  30. https://wicbreastfeeding.fns.usda.gov/phases-breast-milk
  31. https://www.ncbi.nlm.nih.gov/books/NBK499981/
  32. https://pubmed.ncbi.nlm.nih.gov/1420576/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC6013763/
  34. https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr1401
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC3038423/
  36. https://www.sciencedirect.com/science/article/pii/S0012160618302677
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC10326422/
  38. https://medlineplus.gov/ency/article/003999.htm
  39. https://www.sciencedirect.com/science/article/pii/S2352304225000959
  40. https://www.sciencedirect.com/science/article/pii/S0378378225001665
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC4613853/
  42. https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-020-01299-2
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC12009883/
  44. https://www.nature.com/articles/s41574-022-00742-y
  45. https://pubmed.ncbi.nlm.nih.gov/12160086/
  46. https://www.jidonline.org/article/S0022-202X%2815%2944324-6/fulltext
  47. https://pubmed.ncbi.nlm.nih.gov/36192506/
  48. https://www.sciencedirect.com/science/article/abs/pii/S0031395505702844
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC11127660/
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC3586783/
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC7402982/
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC4880877/
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC4818943/
  54. https://www.sciencedirect.com/topics/immunology-and-microbiology/lactation
  55. https://www.ncbi.nlm.nih.gov/books/NBK148970/
  56. https://pubmed.ncbi.nlm.nih.gov/10887504/
  57. https://www.ncbi.nlm.nih.gov/books/NBK235589/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC8594038/
  59. https://pubmed.ncbi.nlm.nih.gov/15954070/
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC5901002/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC10717399/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC11899335/
  63. https://www.ncbi.nlm.nih.gov/books/NBK557782/
  64. https://www.mayoclinic.org/diseases-conditions/mastitis/symptoms-causes/syc-20374829
  65. https://www.mayoclinic.org/diseases-conditions/mastitis/diagnosis-treatment/drc-20374834
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC7672676/
  67. https://www.ncbi.nlm.nih.gov/books/NBK551609/
  68. https://pubmed.ncbi.nlm.nih.gov/35017277/
  69. https://pubmed.ncbi.nlm.nih.gov/32965867/
  70. https://www.ncbi.nlm.nih.gov/books/NBK537115/
  71. https://www.mayoclinic.org/diseases-conditions/galactorrhea/symptoms-causes/syc-20350431
  72. https://www.mayoclinic.org/diseases-conditions/galactorrhea/diagnosis-treatment/drc-20350434
  73. https://pubmed.ncbi.nlm.nih.gov/15317441/
  74. https://www.ncbi.nlm.nih.gov/books/NBK563190/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC6168189/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC11346752/
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC2687418/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC10899808/
  79. https://www.ncbi.nlm.nih.gov/books/NBK562195/
  80. https://www.ncbi.nlm.nih.gov/books/NBK279105/
  81. https://www.cancer.org/cancer/types/breast-cancer-in-men/about/key-statistics.html
  82. https://seer.cancer.gov/statfacts/html/breast.html
  83. https://www.cancer.gov/types/breast/hp/breast-treatment-pdq
  84. https://www.cancer.gov/types/breast/risk-fact-sheet
  85. https://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq
  86. https://training.seer.cancer.gov/breast/types.html
  87. https://seer.cancer.gov/tools/mphrules/2007/breast/terms_defs.pdf
  88. https://www.cancer.gov/types/breast/hp/breast-screening-pdq
  89. https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet
  90. https://repository.si.edu/server/api/core/bitstreams/de56838b-8a00-448c-93ee-653aab8fae49/content
  91. https://science.umd.edu/classroom/bsci338m/Lectures/Monotremes.html
  92. https://www.publish.csiro.au/zo/ZO12088
  93. https://rep.bioscientifica.com/downloadpdf/view/journals/rep/65/2/jrf_65_2_037.pdf
  94. https://academic.oup.com/af/article/13/3/51/7197939
  95. https://www.researchgate.net/publication/291068331_MAMMARY_GLAND_Anatomy
  96. https://pubmed.ncbi.nlm.nih.gov/10882306/
  97. https://academic.oup.com/af/article/13/3/93/7197933
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC4224336/
  99. https://www.mdpi.com/1422-0067/23/7/3883
  100. https://uwmril.wisc.edu/wp-content/uploads/sites/306/2021/08/1_TECH_1_CowIntroUdderAnatomy.pdf
  101. https://open.lib.umn.edu/largeanimalsurgery/chapter/udder-anatomy/
  102. https://jbiol.biomedcentral.com/articles/10.1186/jbiol139
  103. https://www.sciencedirect.com/science/article/pii/S1751731111001935
  104. https://link.springer.com/article/10.1023/A:1022896515287
Add your contribution
Related Hubs
User Avatar
No comments yet.